92 related articles for article (PubMed ID: 8681957)
1. Synthesis and differential properties of creatine analogues as inhibitors for human creatine kinase isoenzymes.
Min KL; Steghens JP; Henry R; Doutheau A; Collombel C
Eur J Biochem; 1996 Jun; 238(2):446-52. PubMed ID: 8681957
[TBL] [Abstract][Full Text] [Related]
2. N-dibenzylphospho-N'-3-(2,6-dichlorophenyl)propyl-guanidine is a bisubstrate-analog for creatine kinase.
Min KL; Steghens JP; Henry R; Doutheau A; Collombel C
Biochim Biophys Acta; 1997 Sep; 1342(1):83-9. PubMed ID: 9366273
[TBL] [Abstract][Full Text] [Related]
3. Dichloroaromatic phosphoguanidines are potent inhibitors but very poor substrates for cytosolic creatine kinase.
Min KL; Steghens JP; Henry R; Doutheau A; Collombel C
Biochim Biophys Acta; 1997 Jun; 1357(1):49-56. PubMed ID: 9202174
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues.
Wendt S; Schlattner U; Wallimann T
J Biol Chem; 2003 Jan; 278(2):1125-30. PubMed ID: 12401781
[TBL] [Abstract][Full Text] [Related]
5. The isoenzyme-diagnostic regions of muscle-type creatine kinase, the M-260 and M-300 box, are not responsible for its binding to the myofibrillar M-band.
Stolz M; Kraft T; Wallimann T
Eur J Cell Biol; 1998 Sep; 77(1):1-9. PubMed ID: 9808283
[TBL] [Abstract][Full Text] [Related]
6. Mutagenesis of two acidic active site residues in human muscle creatine kinase: implications for the catalytic mechanism.
Cantwell JS; Novak WR; Wang PF; McLeish MJ; Kenyon GL; Babbitt PC
Biochemistry; 2001 Mar; 40(10):3056-61. PubMed ID: 11258919
[TBL] [Abstract][Full Text] [Related]
7. Effect of Cd2+ on muscle type of creatine kinase: Inhibition kinetics integrating computational simulations.
Cai Y; Lee J; Wang W; Yang JM; Qian GY
Int J Biol Macromol; 2016 Feb; 83():233-41. PubMed ID: 26642840
[TBL] [Abstract][Full Text] [Related]
8. Spin-labeling probe on conformational change at the active sites of creatine kinase during denaturation by guanidine hydrochloride.
Liu ZJ; Zhou JM
Biochim Biophys Acta; 1995 Nov; 1253(1):63-8. PubMed ID: 7492601
[TBL] [Abstract][Full Text] [Related]
9. [Properties of human creatine kinase isoenzymes].
Malakhov VN; Tishchenko VA; Efron II; Chukhriĭ EA; Isachenkov VA
Biokhimiia; 1977 Jul; 42(7):1221-31. PubMed ID: 20162
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of slow reversible inhibition of human muscle creatine kinase by planar anions.
Luo W; Xie WZ; Bai JH; Zhou HM
J Biochem; 1998 Oct; 124(4):702-6. PubMed ID: 9756613
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial creatine kinase from human heart muscle: purification and characterization of the crystallized isoenzyme.
Blum HE; Deus B; Gerok W
J Biochem; 1983 Oct; 94(4):1247-57. PubMed ID: 6418727
[TBL] [Abstract][Full Text] [Related]
12. Conformationally restricted creatine analogues and substrate specificity of rabbit muscle creatine kinase.
Dietrich RF; Miller RB; Kenyon GL; Leyh TS; Reed GH
Biochemistry; 1980 Jul; 19(14):3180-6. PubMed ID: 6250555
[No Abstract] [Full Text] [Related]
13. Interaction of brain-type creatine kinase with its transition state analog: kinetics of inhibition and conformational changes.
Grossman SH; Garcia-Rubio LH
J Enzyme Inhib; 1987; 1(4):301-9. PubMed ID: 3150431
[TBL] [Abstract][Full Text] [Related]
14. NMR screening applied to the fragment-based generation of inhibitors of creatine kinase exploiting a new interaction proximate to the ATP binding site.
Bretonnet AS; Jochum A; Walker O; Krimm I; Goekjian P; Marcillat O; Lancelin JM
J Med Chem; 2007 Apr; 50(8):1865-75. PubMed ID: 17375903
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
16. The active site of creatine kinase. Affinity labeling of cysteine 282 with N-(2,3-epoxypropyl)-N-amidinoglycine.
Buechter DD; Medzihradszky KF; Burlingame AL; Kenyon GL
J Biol Chem; 1992 Feb; 267(4):2173-8. PubMed ID: 1733925
[TBL] [Abstract][Full Text] [Related]
17. Identification of the creatine binding domain of creatine kinase by photoaffinity labeling.
Min KL; Steghens JP; Henry R; Doutheau A; Collombel C
Biochim Biophys Acta; 1998 Sep; 1387(1-2):80-8. PubMed ID: 9748514
[TBL] [Abstract][Full Text] [Related]
18. Affinity labeling of creatine kinase by N-(2,3-epoxypropyl)-N-amidinoglycine.
Marletta MA; Kenyon GL
J Biol Chem; 1979 Mar; 254(6):1879-86. PubMed ID: 422560
[No Abstract] [Full Text] [Related]
19. Reversible dissociation and unfolding of dimeric creatine kinase isoenzyme MM in guanidine hydrochloride and urea.
Couthon F; Clottes E; Ebel C; Vial C
Eur J Biochem; 1995 Nov; 234(1):160-70. PubMed ID: 8529636
[TBL] [Abstract][Full Text] [Related]
20. In vivo brain phosphocreatine and ATP regulation in mice fed a creatine analog.
Holtzman D; Meyers R; O'Gorman E; Khait I; Wallimann T; Allred E; Jensen F
Am J Physiol; 1997 May; 272(5 Pt 1):C1567-77. PubMed ID: 9176148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
